The National Institutes of Health (NIH) has announced a funding opportunity (RFA-AI-24-017) aimed at supporting research on the genomic associations of Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) in immune-mediated diseases. The initiative seeks to define genetic variations linked to these diseases, elucidate their underlying mechanisms, and enhance predictive screening for clinical outcomes, with a strong emphasis on diversity in research cohorts. Eligible applicants include a wide range of institutions, such as educational, nonprofit, and government entities, with an expected funding amount of up to $400,000 per year. Interested parties should note that the application deadline is August 20, 2024, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.